PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,380 | -72.7% | 7,394 | -65.4% | 0.00% | – |
| Q2 2023 | $280,187 | +97.6% | 21,372 | +68.5% | 0.00% | – |
| Q1 2023 | $141,830 | +5414.4% | 12,686 | +4059.3% | 0.00% | – |
| Q4 2022 | $2,572 | -86.5% | 305 | -73.2% | 0.00% | – |
| Q3 2022 | $19,000 | -36.7% | 1,140 | -44.6% | 0.00% | – |
| Q2 2022 | $30,000 | -98.7% | 2,058 | -97.8% | 0.00% | -100.0% |
| Q1 2022 | $2,337,000 | -25.5% | 94,190 | -3.6% | 0.00% | 0.0% |
| Q4 2021 | $3,135,000 | -72.9% | 97,743 | -69.6% | 0.00% | -66.7% |
| Q3 2021 | $11,556,000 | -7.5% | 321,198 | +13.4% | 0.00% | 0.0% |
| Q2 2021 | $12,495,000 | +6.1% | 283,200 | +10.0% | 0.00% | 0.0% |
| Q1 2021 | $11,772,000 | -36.8% | 257,356 | -4.6% | 0.00% | -25.0% |
| Q4 2020 | $18,624,000 | – | 269,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $1,494,000 | 12.13% |
| Miura Global Management | 595,000 | $14,762,000 | 4.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,695,341 | $91,681,000 | 2.05% |
| Millrace Asset Group, Inc. | 78,859 | $1,956,000 | 1.42% |
| NEXT CENTURY GROWTH INVESTORS LLC | 436,034 | $10,818,000 | 1.08% |
| Novo Holdings A/S | 410,155 | $10,176,000 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 589,722 | $14,631,000 | 0.47% |
| Rock Springs Capital Management LP | 702,400 | $17,427,000 | 0.44% |
| RTW INVESTMENTS, LP | 798,255 | $19,805,000 | 0.41% |
| Regis Management CO LLC | 82,070 | $2,036,000 | 0.36% |